Available via license: CC BY-NC 4.0
Content may be subject to copyright.
Case Rep Gastroenterol 2010;4:340–345
DOI: 10.1159/000320649
Published online:
September 15, 2010
© 2010 S. Karger AG, Basel
ISSN 1662–0631
www.karger.com/crg
This is an Open Access article licensed under the terms of the Creative Commons Attribution-
NonCommercial-NoDerivs 3.0 License (www.karger.com/OA-license), applicable to the online
version of the article only. Distribution for non-commercial purposes only.
Yutaka Kojima Department of Surgery, Koshigaya Municipal Hospital
10-47-1, Higashikoshigaya, Koshigaya City, Saitama, 343-8577 (Japan)
Tel. +81 48 965 2221, Fax +81 48 965 3019, E-Mail yutachan10101970 @ yahoo.co.jp
340
Metastatic Small Bowel Tumor
from Descending Colon Cancer
with Extensive Hematogenous
or Lymphogenous Spread:
Survey of the Japanese
Literature
Yutaka Kojima Fumio Matsumoto Yoshi Mikami
Koji Namekata Masahiko Takei
Department of Surgery, Koshigaya Municipal Hospital, Koshigaya City, Japan
Key Words
Metastatic small bowel tumor · Colon cancer
Abstract
We present the case of a 68-year-old female patient who was diagnosed with cancer of
the descending colon in July 1994 and underwent partial resection of the colon (type 2,
moderately to well differentiated adenocarcinoma, se, ly1, v1, n(–)). In April 1996, she
was admitted to a nearby hospital for symptoms of ileus, which improved at the hospital.
However, she was referred to our hospital for melena. In blood test, Hb was 8.7 g/dl,
showing anemia, and carcinoembryonic antigen level was elevated to 50.7 ng/ml.
Abdominal CT and small bowel series showed only mild expansion of the small bowel,
suggesting no obvious occlusion. Abdominal surgery was performed in May 1995 for
repeated development of ileus symptoms and suspicion of bleeding from the small
bowel. Since the findings of the abdominal surgery showed a circular tumor in the
lower ileum, partial resection of the small bowel was performed. Histopathological
examination showed type 3, moderately to well differentiated adnocarcinoma, se,
ly2, v0, n = 1/13. The principal tumor was located within the subserosa and grew up
exclusively through the muscularis propria and the submucosa, into the mucous layer.
The mucosa remained slightly on the surface layer. Based on these findings, the patient
was diagnosed with metastasis of descending colon cancer to the small bowel. Her
prognosis was good, and neither metastasis nor redevelopment of the cancer have been
confirmed to date, 11 years and 7 months since the surgery.
Case Rep Gastroenterol 2010;4:340–345
DOI: 10.1159/000320649
Published online:
September 15, 2010
© 2010 S. Karger AG, Basel
ISSN 1662–0631
www.karger.com/crg
341
Introduction
The most common primary focus of metastatic tumor of the small intestine is lung
cancer, followed by breast cancer and gastric cancer. The incidence of metastasis from
colon cancer is rare [1], but the majority of cases involve invasive/disseminated metastasis
and there have been a few reports of hematogenous metastasis to the vascular system. We
experienced a case of suspected hematogenous metastasis to the small intestine from
descending colon cancer.
Case Report
A 68-year-old female presented with the chief complaint of melena. Her medical history were
hypertension (from the age of 55 years) and femoral neck fracture (at 60 years). A partial colonic
resection was performed for the diagnosis of descending colon cancer in July 1994 (type 2, 45 × 35 mm,
moderately to well differentiated adenocarcinoma, se, ly1, v1, n(–), H(–), P(–), M(–)). Ileus had
occurred several times since October 1995 and had been alleviated by conservative therapy. She was
referred to a local physician in April 1996. The symptom subsided but melena occurred. She was
referred to our hospital and hospitalized for detailed examination and treatment. Status at admission
was: body temperature 36.7°C, blood pressure 135/72 mm Hg, pulse rate 79/min, regular pulse. No
abnormal findings were observed in the abdomen. Blood test on admission indicated Hb 8.7 g/dl, i.e.
anemia. Carcinoembryonic antigen (CEA) level was elevated to 50.7 ng/ml. According to the follow-up
at the outpatient department, CEA level remained high, 52 ng/ml, before the surgery for the descending
colon cancer. Although the CEA level decreased after surgery, it increased slightly and ranged between
10 and 30 ng/ml (fig. 1). Abdominal X-rays revealed gas masses throughout the entire small intestine
without niveau.
Abdominal CT revealed mild dilation of the small intestine but no findings that suggested obvious
metastasis or relapse of cancer. Gastroscopy and colonoscopy showed no abnormal findings. Small
bowel series revealed mild dilation throughout the whole of the small intestine but no findings that
indicated obvious stenosis or occlusion. Based on the above-mentioned findings, the patient was
diagnosed as having repeated ileus and possible small intestine hemorrhage, and laparotomy was
performed in May 1996. Intraoperative findings demonstrated neither ascites nor peritoneal metastasis.
The lesion encircled the lower ileum, where mild contraction was observed in the serosa and the
mesenterium, but there was no evidence of exposed tumor. A partial small bowel resection including the
tumor area was performed. Fresh specimen revealed a type 3-like circumferential tumor in the ileum,
30 × 50 mm in size (fig. 2). Mild contraction was found in the serosal surface, but there was no evidence
of exposed tumor. Pathohistological examination revealed that the main lesion of the tumor was located
within the subserosa and grew up exclusively through the muscularis propria and the submucosa, into
the mucous layer, which was similar to the histopathologic image of the descending colon cancer
isolated in 1994 (fig. 3). In addition, there were no operative findings to indicate the presence of
invasive/disseminated metastasis. Therefore the patient was diagnosed as having hematogenous
metastasis to the small intestine. She was discharged in excellent condition. At present, 11 years and
7 months after the surgery, neither relapse nor metastasis have been observed.
Discussion
The incidence of metastatic tumors in the small intestine is relatively rare, and
2.8–8.2% have been identified in autopsy cases [2–6]. The routes of metastasis to the
small intestine include hematogenous metastasis (a tumor grows within the intestinal
wall and spreads via hematogenous or lymphatic routes), peritoneal metastasis (a tumor,
which disseminates and invades into the serosa and the mesenterium, continuously
increases within the intestinal wall), and intestinal metastasis (tumor cells, which are
liberated/drop out into the intestinal tract, are implanted into the intestinal mucosa and
Case Rep Gastroenterol 2010;4:340–345
DOI: 10.1159/000320649
Published online:
September 15, 2010
© 2010 S. Karger AG, Basel
ISSN 1662–0631
www.karger.com/crg
342
grow). On the other hand, the major route of metastasis of colon cancer to the small
intestine is disseminated metastasis associated with peritonitis carcinomatosa [3].
The reported number of suspected cases of hematogenous metastasis of colon cancer,
like our case, was only 6 from 1983 to 2007 in Japan. We reviewed a total of 7 patients,
including the above-mentioned 6 patients and our patient (table 1) [1, 7–11]. The ages of
the patients, including 4 males and 3 females, ranged from 60 to 80 years, with a mean of
69.0 years. Therefore no sex difference was observed. Their main symptoms included
obstructive symptoms, such as abdominal bloating, vomiting, and constipation, and
bleeding symptoms, such as occult blood and melena caused by bleeding from tumors.
In addition to tumor occlusion and hemorrhage, perforation and palpable abdominal
mass are generally seen [6]. The most common primary site among the cases reviewed
was the sigmoid colon in 3 patients, and the ascending colon, the transverse colon, the
descending colon, and the rectum in 1 patient each. The histopathological diagnosis
indicated that the number of moderately differentiated adenocarcinomas, low to
moderately differentiated adenocarcinomas, and moderately to well differentiated
adenocarcinomas were 5, 1, and 1, respectively, and that there were no remarkable
profiles. The tumor progression was high and the depth of the tumor invasion was more
than the subserosal layer in all of the patients. The hematogenous and lymphatic invasion
level, ly1, v1 and greater, was observed in all of the patients. With the exception of
1 patient whose metastasis site was both the jejunum and the ileum, the metastasis site of
the remaining patients was the ileum in 5 patients and the jejunum in 1 patient. Thus, the
ileum was the most common metastasis site. One patient in the review had 3 metastases in
total, including 1 in the jejunum and 2 in the ileum, and 1 patient had 2 metastases in the
ileum. The remaining patients had only 1 metastatic focus.
In terms of time to diagnosis, synchronous metastasis was observed in 2 patients,
and metachronous metastasis took from 1 year and 8 months to 9 years, with a mean of
3 years and 7 months after surgery. One patient had metastasis to the lung and the liver
and all of the remaining patients had metastasis to the small intestine alone. The majority
had a solitary metastasis.
The most common method of clinical diagnosis of metastatic carcinoma of the small
intestine is a small bowel series. The typical findings are that (1) it has a submucosal
tumor with a clear-cut margin and central depression called the bull’s eye sign, and that
(2) it exhibits fold convergency transverse to the longitudinal axis of the bowel lumen
(transverse stretch) [6]. However, in this review there were no cases in whom a
preoperative diagnosis was established. They were found during surgery for intestinal
obstruction in 3 patients, during surgery for the primary focus in 2 patients, and during
surgery for anastomotic recurrence of the primary focus in 1 patient. Our case underwent
surgical treatment for repeated intestinal obstruction and small intestinal bleeding, but
there was no remarkable abnormality, so that a preoperative definitive diagnosis was not
established. The surgical procedures conducted in this review were ileocecal resection in
3 patients, partial small bowel resection in 3 patients, and right hemicolectomy in
1 patient. All of the patients underwent tumor resection containing the primary focus.
The histopathological findings in the cases of hematogenous metastasis to the small
intestine indicated distant metastasis to the submucosa and/or muscularis propria and
temporal increase of the primary focus in the mucosal and serosal sides. Therefore, unlike
tumors that invade directly and metastasize to the small intestine, a primary focus close to
Case Rep Gastroenterol 2010;4:340–345
DOI: 10.1159/000320649
Published online:
September 15, 2010
© 2010 S. Karger AG, Basel
ISSN 1662–0631
www.karger.com/crg
343
the serosa may develop into an extra-gastrointestinal tumor or submucosal tumor,
whereas a primary metastasis close to the mucosal side is likely to form an ulcer but may
have partially retained morphology of a submucosal tumor [8]. All 10 of the primary foci
studied in this review included 5 submucosal tumor-like lesions, 2 type 2-like lesions,
1 type 3-like lesion, 1 type 1-like lesion, and 1 cerebriform lesion.
In general, it has been reported that the prognosis of metastasis to the small intestine
is poor. Metastatic tumors are normally found as a result of the presence of remarkable
symptoms, such as gastrointestinal bleeding, intestinal obstruction, and intestinal
perforation, and these severe findings may lead to the diagnosis [2, 5, 6]. However, in
this review, 4 patients had neither relapse nor metastasis at 6 months, 1 year and 1 month,
2 years and 7 months, and 11 years and 2 months, respectively, and 2 patients survived
for 1 year and 6 months and 2 years and 6 months, except for one death that occurred
1 month after surgery. Accordingly, the long-term prognosis can be expected to improve
by resection of the primary focus.
All cases in this review, except for the cases in whom the metastatic tumor was found
accidentally at the time of operation, had intestinal occlusion. Postoperative intestinal
occlusion is very familiar to surgeons. Tanaka et al. [12] reported that the percentage of
adhesive intestinal obstruction, ileus caused by peritonitis carcinomatosa, and occlusive
ileus caused by tumor was 60.9, 18.5, and 10.7%, respectively, among cases of obturation
ileus. When encountering postoperative intestinal occlusion, which results from a
malignant tumor, the possibility of metastasis to the small intestine as well as adhesive
intestinal obstruction should be considered.
Table 1. Reported cases of metastatic small bowel tumor from colon cancer with extensive
hematogenous or lymphogenous spread in Japan
First author Age/sex Chief complaint Locationa Histology Durationb Locationc Prognosis
Yamamoto (1997)
[8]
76/M abdominal
distention
S/C mod, ss, ly3, v1, n1(+) 9 years ileum alive (13 months),
no recurrence
Niwa (2003)
[9]
69/F vomiting T/C mod, ss, ly2, v2, n(–) 3 years jejunum alive (6 months),
no recurrence
Ishida (2003)
[10]
80/F constipation A/C poor–mod same time ileum death (1 month)
Kuroda (2005)
[1]
62/M general
fatigue
S/C mod, ss, ly1, v3 same time jejunum
and ileum
alive (31 months),
no recurrence
Takeshita (2006)
[11]
60/M constipation rectum mod, ss, ly1, v1, n3(+) 2.5 years ileum alive (30 months)
Tsujimura (2007)
[7]
68/M none S/C mod, ss, ly2, v2, n1(+) 2 years ileum alive (18 months)
Our case 68/F melena D/C mod–well, se, ly1, v1, n(–) 1.6 years ileum alive (134 months),
no recurrence
a Location of primary lesion. b Duration before detection of metastatic tumor. c Location of metastatic lesion.
Case Rep Gastroenterol 2010;4:340–345
DOI: 10.1159/000320649
Published online:
September 15, 2010
© 2010 S. Karger AG, Basel
ISSN 1662–0631
www.karger.com/crg
344
Fig. 1. The transition of serum CEA.
Fig. 2. Macroscopic findings of the mucosal side of the resected small intenstine.
Fig. 3. Histological appearance of the primary descending colon cancer (a) and metastatic tumor (b).
Note the similar histological features.
Case Rep Gastroenterol 2010;4:340–345
DOI: 10.1159/000320649
Published online:
September 15, 2010
© 2010 S. Karger AG, Basel
ISSN 1662–0631
www.karger.com/crg
345
References
1 Kuroda M, Tanaka Y, Usami K, Yoshitani S, Kita I, Takashima S: A case of multiple sigmoid colon cancer
which metastasized to the small intestine. J Jpn Surg Assoc 2005;66:1119–1124.
2 Masaoka K, Nakamura T: Metastatic neoplasms of the bowel. Nippon Rinsho 1994;suppl 6:612–615.
3 DeCastro CA, Dockerty MB, Mayo CW: Metastatic tumors of the small intestines. Surg Gynecol Obstet
1957;105:159–165.
4 Farmer RG, Hawk WA: Metastatic tumors of the small bowel. Gastroenterology 1964;47:496–504.
5 Routh A, Hickman BT: Metastatic tumors of the small intestine: case report and review of literature. J Miss
State Med Assoc 1984;25:235–236.
6 Ushio K, Ishikawa T, Miyagawa K: X-ray diagnosis of metastatic small intestinal tumor. I to Cho 1992;27:
793–804.
7 Tsujimura T, Toyokawa A, Wakahara T, Mukubou H, Hamabe Y: A case of solitary metastasis of sigmoid
colon cancer to the small intestine. Jpn J Gastroenterol Surg 2007;40:141–145.
8 Yamamoto M, Karasawa G, Hirata K, Konishi Y, Takada Y, Yokoyama S: A case of strongly-suspected
hematogenous metastasis after surgery for sigmoid colon cancer. Hokkaido J Surg 1997;42:199–200.
9 Niwa H, Morikane K, Naka S, Morikane K, Nka H, Yasuhara H: Recurrent tumor of the small intestine after
transverse colon cancer surgery. Shujyutsu 2003;57:527–531.
10 Ishida T, Kato T, Ito Y, Hukuhara R, Yamazaki M: A case of possible synchronous lymph node metastasis of
ascending colon cancer to the small intestine. Mie-Igaku 2003;46:81–84.
11 Takeshita H, Tsuji T, Sawai T, Takasaki H, Deguchi M, Yasutake T, Nagayasu T: A case of a metastatic jejunal
tumor that developed intestinal occlusion 2.5 years after surgery for rectal cancer. J Jpn Surg Assoc
2006;67:640–644.
12 Tanaka N, Onda M, Takasaki H, Yoshimura K, Yokoyama S, Sasabe H, Nagashima Y: Cause and
pathophysiology of ileus. Shokaki Geka 1996;19:1787–1792.